BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9031116)

  • 1. Effects of interferon-alpha and -gamma on B cell differentiation in macroglobulinemia.
    Levy Y; Chedeville A; Brouet JC
    Leuk Lymphoma; 1996 Oct; 23(3-4):347-51. PubMed ID: 9031116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of spontaneous B-cell differentiation in macroglobulinemia by retinoic acid.
    Levy Y; Labaume S; Gendron MC; Brouet JC
    Blood; 1994 Apr; 83(8):2206-10. PubMed ID: 8161786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in lymphocyte profile and specificity repertoire of patients with Waldenstrom's macroglobulinemia, multiple myeloma, and IgM monoclonal gammopathy of undetermined significance.
    Pilarski LM; Andrews EJ; Serra HM; Ledbetter JA; Ruether BA; Mant MJ
    Am J Hematol; 1989 Feb; 30(2):53-60. PubMed ID: 2536515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of heavy chain immunoglobulin gene rearrangements in Waldenström's macroglobulinemia and IgM monoclonal gammopathy of undetermined significance.
    Martín-Jiménez P; García-Sanz R; Balanzategui A; Alcoceba M; Ocio E; Sanchez ML; González M; San Miguel J
    Haematologica; 2007 May; 92(5):635-42. PubMed ID: 17488687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A phase II trial on alpha-interferon (alpha IFN) effect in patients with monoclonal IgM gammopathy.
    Rotoli B; De Renzo A; Frigeri F; Buffardi S; Marcenò R; Cavallaro AM; Ruggeri P; Liso V; Musto P; Andriani A
    Leuk Lymphoma; 1994 May; 13(5-6):463-9. PubMed ID: 8069191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification.
    Paiva B; Montes MC; García-Sanz R; Ocio EM; Alonso J; de Las Heras N; Escalante F; Cuello R; de Coca AG; Galende J; Hernández J; Sierra M; Martin A; Pardal E; Bárez A; Alonso J; Suarez L; González-López TJ; Perez JJ; Orfao A; Vidríales MB; San Miguel JF
    Leukemia; 2014 Jan; 28(1):166-73. PubMed ID: 23604227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.
    Varettoni M; Zibellini S; Capello D; Arcaini L; Rossi D; Pascutto C; Rattotti S; Mangiacavalli S; Pochintesta L; Gotti M; Gaidano G; Cazzola M
    Leuk Lymphoma; 2013 Nov; 54(11):2485-9. PubMed ID: 23442064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Origins of Waldenstrom's macroglobulinemia: does it arise from an unusual B-cell precursor?
    Kriangkum J; Taylor BJ; Reiman T; Belch AR; Pilarski LM
    Clin Lymphoma; 2005 Mar; 5(4):217-9. PubMed ID: 15794851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cellular origin and malignant transformation of Waldenström macroglobulinemia.
    Paiva B; Corchete LA; Vidriales MB; García-Sanz R; Perez JJ; Aires-Mejia I; Sanchez ML; Barcena P; Alignani D; Jimenez C; Sarasquete ME; Mateos MV; Ocio EM; Puig N; Escalante F; Hernández J; Cuello R; García de Coca A; Sierra M; Montes MC; González-López TJ; Galende J; Bárez A; Alonso J; Pardal E; Orfao A; Gutierrez NC; San Miguel JF
    Blood; 2015 Apr; 125(15):2370-80. PubMed ID: 25655603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression from Monoclonal gammopathy of undetermined significance of the immunoglobulin M class (IgM-MGUS) to Waldenstrom Macroglobulinemia is associated with an alteration in lipid metabolism.
    Jalali S; Shi J; Ahsan N; Wellik L; Serres M; Buko A; Paludo J; Kim H; Tang X; Yang ZZ; Novak A; Kyle R; Ansell S
    Redox Biol; 2021 May; 41():101927. PubMed ID: 33690107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling of B lymphocytes and plasma cells from Waldenström's macroglobulinemia: comparison with expression patterns of the same cell counterparts from chronic lymphocytic leukemia, multiple myeloma and normal individuals.
    Gutiérrez NC; Ocio EM; de Las Rivas J; Maiso P; Delgado M; Fermiñán E; Arcos MJ; Sánchez ML; Hernández JM; San Miguel JF
    Leukemia; 2007 Mar; 21(3):541-9. PubMed ID: 17252022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.
    Sahota SS; Forconi F; Ottensmeier CH; Stevenson FK
    Semin Oncol; 2003 Apr; 30(2):136-41. PubMed ID: 12720123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin heavy chain sequence analysis in Waldenstrom's macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance.
    Rollett RA; Wilkinson EJ; Gonzalez D; Fenton JA; Short MA; Evans PA; Rawstron AC; Owen RG
    Clin Lymphoma Myeloma; 2006 Jul; 7(1):70-2. PubMed ID: 16879773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel aspects pertaining to the relationship of Waldenström's macroglobulinemia, IgM monoclonal gammopathy of undetermined significance, polyclonal gammopathy, and hypoglobulinemia.
    McMaster ML; Kristinsson SY; Turesson I; Björkholm M; Landgren O
    Clin Lymphoma Myeloma; 2009 Mar; 9(1):19-22. PubMed ID: 19362963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA; Dispenzieri A; Kumar S; Larson D; Therneau T; Rajkumar SV
    Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):74-6. PubMed ID: 21454195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neuropathies of Waldenström's macroglobulinemia (WM) and IgM-MGUS.
    Klein CJ; Moon JS; Mauermann ML; Zeldenrust SR; Wu Y; Dispenzieri A; Dyck PJ
    Can J Neurol Sci; 2011 Mar; 38(2):289-95. PubMed ID: 21320835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 6 dependence of spontaneous in vitro differentiation of B cells from patients with IgM gammapathy.
    Levy Y; Fermand JP; Navarro S; Schmitt C; Vainchenker W; Seligmann M; Brouet JC
    Proc Natl Acad Sci U S A; 1990 May; 87(9):3309-13. PubMed ID: 2333285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.